FDA Approves Supplement for Fluorescite by Alcon Labs
The FDA has approved a supplemental application for Fluorescite, which contains fluorescein sodium.
Company
Pharmaceutical intelligence for Alcon Labs with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.